Journal of Clinical Investigation · 1993 · 468 citations · 42 references
Life SciencesImmunologyMicrobiologyInnate ImmunityMolecular VirologyVirologyAntiviral ImmunityAntiviral PharmacologyViral InfectionsViral ReplicationAntiviral Mechanisms Of ActionNitric OxideNitric Oxide BiologyNitric Oxide DonorsNitric Oxide ModulationNoncompetitive InhibitionViral Replication InhibitionViral Replication Inhibitors
Nitric oxide (NO) has antimicrobial activity against a wide spectrum of infectious pathogens, but an antiviral effect has not been reported. The impact of NO, from endogenous and exogenous sources, on herpes simplex virus type 1 (HSV 1) replication was studied in vitro. HSV 1 replication in RAW 264.7 macrophages was reduced 1,806-fold in monolayers induced to make NO by activation with gamma IFN and LPS. A competitive and a noncompetitive inhibitor of nitric oxide synthetase substantially reduced the antiviral effect of activated RAW macrophages. S-nitroso-L-acetyl penicillamine (SNAP) is a donor of NO and was added to the media of infected monolayers to assess the antiviral properties of NO in the absence of gamma IFN and LPS. A single dose of S-nitroso-L-acetyl penicillamine 3 h after infection inhibited HSV 1 replication in Vero, HEp2, and RAW 264.7 cells in a dose-dependent manner. Neither virucidal nor cytocidal effects of NO were observed under conditions that inhibited HSV 1 replication. Nitric oxide had inhibitory effects, comparable to that of gamma IFN/LPS, on protein and DNA synthesis as well as on cell replication. This report demonstrates that, among its diverse properties, NO has an antiviral effect.
42
Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids
Laura C. Green, David A. Wagner, Joseph A. Glogowski et al. · Analytical Biochemistry · 1982 · 12.1K citations
L J Ignarro, Howard Lippton, Jo C. W. Edwards et al. · Journal of Pharmacology and Experimental Therapeutics · 1981 · 1.6K citations